-transparent.png){kind=logo}
As the proportion of patients with rheumatoid arthritis (RA) who have anti-keratin antibodies (AKA) varies in different ethnic groups, we studied its occurrence in a hospital populations with RA and its association with different disease variables. Sera from 84 consecutive patients with RA, 100 healthy controls and 85 disease controls (polyarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis) were tested for AKA by an indirect immunofluorescence assay that used rat esophagus as substrate. The proportion of patients with RA who had AKA (47/84) was higher than in healthy controls (2/100; P < 0.001) and in disease controls (2/85; P < 0.001). The frequency of AKA positivity was higher among patients who had severe disease (P < 0.05) and rheumatoid factor. Anti-keratin antibody is present in 56 per cent of our patients with RA and is associated with severe disease.
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
July 1979,
British medical journal,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
March 2011,
La Tunisie medicale,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
November 1986,
Revue du rhumatisme et des maladies osteo-articulaires,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
January 2001,
Clinical and experimental rheumatology,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
July 2002,
Rheumatology (Oxford, England),
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
June 1981,
Annals of the rheumatic diseases,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
January 1983,
Clinical and experimental immunology,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
February 1987,
Clinical immunology and immunopathology,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
January 1993,
Advances in experimental medicine and biology,
B L Sharma, and
R Rani, and
R Misra, and
A Aggarwal
January 2001,
Clinical and experimental rheumatology,
